Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Short Interest Update

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 386,800 shares, a decrease of 32.2% from the April 30th total of 570,200 shares. Based on an average daily volume of 151,200 shares, the […]

Related Keywords

Michael Ackermann ,Morgan Stanley ,Vivo Capital Ix Llc ,Tarsus Pharmaceuticals Inc ,Zacks Investment Research ,Ensign Peak Advisors Inc ,Nasdaq ,Frazier Life Sciences Management ,Jpmorgan Chase Co ,Tarsus Pharmaceuticals Get Rating ,Tarsus Pharmaceuticals ,Get Rating ,Director Michael Ackermann ,Peak Advisors Inc ,Investment Research ,Nasdaq Tars ,Stars ,Medical ,Stocks ,Options ,Put ,Call ,